ImaginAb
PrivateLast Round
Series C
Extension
Sep 14, 2023
Total Funding Raised
$57.8M
Company Overview
ImaginAb is a biotechnology company that develops radiopharmaceutical imaging agents and therapies, including its proprietary CD8 ImmunoPET technology for cancer immunotherapy monitoring.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Imaging, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImaginAb Comparables
Compare ImaginAb with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CellSight Technologies | 86% | |
| Suzhou SmartNuclide Biopharmaceutical Co., Ltd. | 76% | |
| Bracco S.p.A. | 74% | |
ImaginAb Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Sep 14, 2023 | ||||
| Series C Extension | Mar 14, 2023 | ||||
| Series C | Jun 3, 2021 | ||||
| Series B Extension | Oct 9, 2017 | ||||
| Series B | May 8, 2014 | ||||
Series A | Mar 26, 2012 |
ImaginAb Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Norgine Ventures | Series C |
| Momentum Biosciences | Series A |
| Parker Institute for Cancer Immunotherapy | Series B Extension |
| Innoviva | Series C Extension |
| Cycad Group | Series A, Series B Extension, Series B, Series C |
| The Raptor Group | Series B Extension, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 9, 2017
$8M round led by Adage Capital Management.
- May 8, 2014
$21M round led by Mérieux Equity Partners.
ImaginAb Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ImaginAb's valuation, stock price, and market status.